used scRNA‐seq to construct a lineage map of resistance to anti‐EGFR therapy in triple‐negative breast cancer, which successfully revealed the dynamic changes in tumor clones and mechanisms of tumor resistance.61 This evidence concerns the gene EGFR and neoplasm.